XYMOGEN
Violation History
1 incident
Fda Warning
The warning letter cited violations of current Good Manufacturing Practice (cGMP) regulations for dietary supplements, including failure to establish product specifications for the identity, purity, strength, and composition of the finished dietary supplement, and failure to conduct at least one appropriate test or examination to verify the identity of a dietary ingredient. The letter also noted that several products were considered new drugs because they were not generally recognized as safe and effective for their intended use.2011-12-13Source
Nattokinase, 60 Vegetarian Capsules
Product 75
Brand 96
PepciX, 60 Chewable Tablets
Product 75
Brand 96
Magnesium Citrate, 120 Vegetarian Capsules
Product 75
Brand 96
CurcuPlex-95, 60 Vegetarian Capsules
Product 75
Brand 96
T-150, 60 Vegetarian Capsules
Product 75
Brand 96
CoQmax Omega, 100 mg, 60 Softgels
Product 75
Brand 96
Quercetin 20x Plus, 120 Vegetarian Capsules
Product 75
Brand 96
K2-45, 60 Vegetarian Capsules
Product 75
Brand 96
CurcuPlex-95, 120 Vegetarian Capsules
Product 75
Brand 96
XymoZyme HCI, 90 Vegetarian Capsules
Product 75
Brand 96
Scan Any Supplement Instantly
Download GoodSupp to scan barcodes and check any XYMOGEN product.
Disclaimer: GoodSupp provides independent supplement quality analysis for informational purposes only. Scores are generated algorithmically based on ingredient profiles, brand certifications, and public records. This is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Product data is sourced from manufacturer labels and public databases. GoodSupp is not affiliated with any supplement brand.